When Is a Medical Product Too Risky?: An Interview with FDA’s Top Drug Official PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download When Is a Medical Product Too Risky?: An Interview with FDA’s Top Drug Official PDF full book. Access full book title When Is a Medical Product Too Risky?: An Interview with FDA’s Top Drug Official by . Download full books in PDF and EPUB format.
Author:
Publisher: DIANE Publishing
ISBN: 9781422326831
Category :
Languages : en
Pages : 16
Get Book Here
Book Description
Author:
Publisher: DIANE Publishing
ISBN: 9781422326831
Category :
Languages : en
Pages : 16
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Consumer protection
Languages : en
Pages : 446
Get Book Here
Book Description
Author: Sophia Dziegielewski
Publisher: W. W. Norton & Company
ISBN: 9780393704594
Category : Medical
Languages : en
Pages : 310
Get Book Here
Book Description
In today's era of managed behavioral health care, mental health professionals are called upon to consult on medication treatment or recommend what medications would best serve as adjuncts to therapy. Medically trained or not, all mental health professionals need to know as much as possible about psychopharmacologic medications from dosage and side effects to drug-drug interactions and other special considerations in order to provide effective and accountable treatment. The first-ever handbook of its kind, Psychopharmacology Handbook for the Non-Medically Trained fills a noticeable gap in most student training programs by providing a reader-friendly and accessible overview of the role of drugs in mental health treatment. Emphasizing the importance of making medications available to consumers in conjunction with the most effective and efficient counseling interventions, Dziegielewski establishes the context for the therapeutic use of psychotropic drugs in the culture of today ís mental health treatments, examines the danger of the "quick fix" mentality into which consumers and clinicians are tempted to fall, and then focuses on the medications themselves. One of the most prominent and authoritative social work academics today, Dziegielewski is an authority on the topic of psychopharmacology in social work practice. The recipient of numerous honors and awards for her teaching, the creator of a popular preparation course for social work licensure, and the author of over 95 publications, she is a source to which students and professionals turn for up-to-date, accurate information on a variety of topics in the social work field. Psychopharmacology Handbook for the Non-Medically Trained is an invaluable resource guide for all non-medically trained practitioners, providing therapists, social workers, and other counselors, with effective tools and critical information to help them become better informed about all courses of mental health treatment for their clients.
Author: Sophia Dziegielewski PhD, LCSW
Publisher: Springer Publishing Company
ISBN: 9780826113948
Category : Social Science
Languages : en
Pages : 352
Get Book Here
Book Description
Why do social workers need to know about mental health medications? How can social workers best assist clients who are taking medications? What is the social worker's role as part of the interdisciplinary health care team? Answering these questions and more, this comprehensive text discusses the major medications used to treat common mental health conditions and offers guidelines on how to best serve clients who are using them. This new edition provides guidance on many issues that social workers will encounter in practice, including identifying potentially dangerous drug interactions and adverse side effects; improving medication compliance; recognizing the warning signs of drug dependence; and understanding how psychopharmacology can work in conjunction with psychosocial interventions. Complete with case examples, assessment tools, and treatment plans, this book offers practical insight for social work students and social workers serving clients with mental health conditions. New to this edition are expanded discussions of child and adolescent disorders, engaging discussions of how new drugs are created, approved, and marketed, and a new glossary describing over 150 common medications and herbal remedies. Important Topics Discussed: Treatment of common mental health conditions, such as depression, anxiety disorders, schizophrenia, and dementia Taking a comprehensive medication history Understanding medical terminology Avoiding drug misuse, dependence, and overdose
Author:
Publisher:
ISBN:
Category : Lawyers
Languages : en
Pages : 1516
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Consumer education
Languages : en
Pages : 540
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309178657
Category : Medical
Languages : en
Pages : 64
Get Book Here
Book Description
Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children-50 to 75 percent-have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: United States. Federal Trade Commission. Bureau of Consumer Protection
Publisher:
ISBN:
Category : Advertising
Languages : en
Pages : 32
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Medical instruments and apparatus
Languages : en
Pages : 4
Get Book Here
Book Description
